Scientists have discovered that breast tumors contain hidden pockets of dormant cancer cells that may survive chemotherapy and later trigger relapse. These quiet cells, which essentially hibernate, are often surrounded by immune and connective tissue cells that act like a protective shield. The finding, published in Genome Medicine, offers a new explanation for why cancer can return years after successful treatment.
The Hidden Danger of Sleeping Cancer Cells
Researchers from the MRC Laboratory of Medical Sciences, Imperial College London, and UCL Genetics Institute built detailed cellular maps of untreated breast tumors. They found distinct regions filled with actively dividing cancer cells and other areas containing dormant, or quiescent, cells. These dormant cells are particularly concerning because they can hide from chemotherapy and remain inactive in the tumor, then reactivate later to drive cancer growth.
Cancer cells enter this dormant state when tumors expand rapidly and blood flow cannot keep pace with nutrient demands. Under such stressful conditions, some cells essentially put their growth on hold. Like a bear hibernating through winter, they wait until the environment becomes more favorable, which may happen after treatment has ended.
Mapping the Tumor Cell by Cell
The team used publicly available data to create high-resolution maps of breast cancer tumors. They identified clusters of quiescent cells surrounded by other cell types that may serve as a protective barrier. The researchers found that these dormant cells are often accompanied by immune cells and connective tissue cells, which may help shield them from treatment.
Dr. Alexis Barr, co-lead author and head of the Cell Cycle Control group at the LMS, emphasized the danger of these cells. She noted that if doctors want to achieve long-term control of tumors and prevent relapse, they must focus on understanding these dormant cancer cells better.
The study suggests that future cancer therapies may need to do more than attack fast-growing tumor cells. They may also need to target dormant cancer cells and the local environments that allow them to persist. This approach could help stop tumor growth while reducing the risk that the disease returns later.
The research was conducted in the United Kingdom, where breast cancer remains a major health concern. The findings could reshape how scientists think about cancer treatment, pointing toward strategies that address not just the visible tumor but also the hidden cells that may cause future problems.
